Goldman Sachs’s Merus Labs International Inc. MSLI Stock Holding History

Goldman Sachs’s Portfolio MSLI Stock Details MSLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,093,541	Closed	-$1.38M	–	7112
2017 Q2	$1.38M	Buy	1,093,541 +1,066,837	+3,995%	+$1.11M	﹤0.01%	4161
2017 Q1	$25K	Sell	26,704 -4,800	-15%	-$4.14K	﹤0.01%	6467
2016 Q4	$27K	Sell	31,504 -12,397	-28%	-$11.4K	﹤0.01%	6571
2016 Q3	$45K	Sell	43,901 -3,998	-8%	-$4.51K	﹤0.01%	6515
2016 Q2	$61K	Buy	47,899 +14,299	+43%	+$20K	﹤0.01%	6352
2016 Q1	$49K	Buy	+33,600	New	+$46.7K	﹤0.01%	6446

Goldman Sachs's MSLI Position: Q3 2017 in Review

Goldman Sachs sold out of Merus Labs International Inc. (MSLI) in Q3 2017, closing a stake of 1,093,541 shares — an estimated $1.38M sold.

Goldman Sachs first reported a position in MSLI in Q1 2016 and held it in 6 quarters. The position peaked at $1.38M in Q2 2017. 0 funds tracked by Wall St. Rank hold MSLI as of Q3 2017.

Goldman Sachs reported no remaining Merus Labs International Inc. position as of Q3 2017 after selling out during the quarter.
Goldman Sachs sold 1,093,541 Merus Labs International Inc. shares in Q3 2017, an estimated $1.38M.
Goldman Sachs first reported a position in Merus Labs International Inc. in Q1 2016 and held it in 6 quarters.
Goldman Sachs's Merus Labs International Inc. position peaked at $1.38M in Q2 2017.
0 funds tracked by Wall St. Rank held Merus Labs International Inc. as of Q3 2017.

Based on Goldman Sachs's 13F filing for Q3 2017, filed 14 Nov 2017.